By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Cingulate Inc.

Cingulate Inc. (CINGW)

NASDAQ Currency in USD
$396.00
-$5.54
-1.38%
Last Update: 18 Jul 2026, 15:53
$2.15bn
Market Cap
-92.96
P/E Ratio (TTM)
Forward Dividend Yield
$291.91-$494.19
52 Week Range

CINGW Stock Price Chart

Explore Cingulate Inc. interactive price chart. Choose custom timeframes to analyze CINGW price movements and trends.

CINGW Company Profile

Discover essential business fundamentals and corporate details for Cingulate Inc. (CINGW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Dec 2021

Employees

13.00

CEO

Shane J. Schaffer

Description

Cingulate Inc. is a biopharmaceutical firm in the clinical development stage, dedicated to pioneering therapies for central nervous system and neurobiological conditions. Its leading investigational medicines are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), both designed to manage attention deficit/hyperactivity disorders (ADHD). Furthermore, the company is progressing CTx-2103 for the treatment of anxiety disorders. Established in 2012, Cingulate Inc. maintains its main office in Kansas City, Kansas, and also operates a facility in Morristown, New Jersey.

CINGW Financial Timeline

Browse a chronological timeline of Cingulate Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 Aug 2026

EPS estimate is -$0.63, while revenue estimate is $166.67k.

Earnings released on 14 May 2026

EPS came in at -$0.95 falling short of the estimated -$0.52 by -82.69%.

Earnings released on 18 Mar 2026

EPS came in at -$0.96 falling short of the estimated -$0.63 by -51.11%.

Earnings released on 13 Nov 2025

EPS came in at -$1.35k falling short of the estimated -$0.88 by -153.50k%.

Earnings released on 19 Aug 2025

EPS came in at -$1.09 falling short of the estimated -$0.92 by -19.23%.

Earnings released on 8 May 2025

EPS came in at -$1.04 falling short of the estimated -$1.01 by -3.50%.

Earnings released on 30 Sept 2023

EPS came in at -$0.00 .

Earnings released on 30 Jun 2023

EPS came in at -$0.57 .

Earnings released on 31 Mar 2023

EPS came in at -$14.06 .

Earnings released on 31 Dec 2022

CINGW Stock Performance

Access detailed CINGW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run